Filter Results:
(3,183)
Show Results For
- All HBS Web
(3,183)
- People (7)
- News (423)
- Research (2,382)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,958)
Show Results For
- All HBS Web
(3,183)
- People (7)
- News (423)
- Research (2,382)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,958)
- May 2024
- Case
SofMedica Group: Managing Growth
By: Boris Groysberg and Sarah L. Abbott
SofMedica Group had expanded from its origins as a medical equipment distributor in Romania to a holding company with four business lines operating in six countries. This expansion had been driven by SofMedica’s mission: to make cutting edge medical technology... View Details
Keywords: Growth; Healthcare Access; Healthcare; Medical Devices; Medical Equipment ＆ Devices; Medical Care; Eastern Europe; Quality Management System; Health Care and Treatment; Growth Management; Education; Organizational Change and Adaptation; Quality; Leadership; Mission and Purpose; Expansion; Developing Countries and Economies; Technological Innovation; Health Industry; Health Industry; Europe; Romania
Groysberg, Boris, and Sarah L. Abbott. "SofMedica Group: Managing Growth." Harvard Business School Case 424-027, May 2024.
- April 2012
- Case
Bella Healthcare India
By: Dorothy Leonard and Sunru Yong
Bella Healthcare India was originally established in Bangalore as a low-cost manufacturing facility for a U.S.-based cardiology equipment developer. Under country manager Joseph Cherian it evolved considerably, developing its own research and development capabilities.... View Details
Keywords: India; Productivity; Organizational Development; International Business; R＆D; Cross-cultural Relations; Medical Equipment ＆ Devices; Joint Ventures; Medical Specialties; Research and Development; Product Development; Organizational Change and Adaptation; Strategy; Decision Choices and Conditions; Health Care and Treatment; Product Launch; Failure; Cross-Cultural and Cross-Border Issues; Medical Devices and Supplies Industry; Bangalore
Leonard, Dorothy, and Sunru Yong. "Bella Healthcare India." Harvard Business School Brief Case 124-440, April 2012.
- 27 Oct 2017
- News
The Best Business Advice I’ve Ever Received
from MBA class, 2002. So after I graduated from 2002, then I stayed in Boston for a year, working here. Then my husband graduated from 2003. So when he graduated, he found a job with United Health Care in Minneapolis. And I said, OK, so... View Details
- June 1990 (Revised June 2004)
- Teaching Note
Nestle Alimentana S.A. -- Infant Formula (Abridged) TN
By: James E. Austin and Tomas Otto Kohn
Teaching Note for (9-590-070). View Details
- 22 Jan 2019
- First Look
New Research and Ideas, January 22, 2019
experimentation that is required for the initial commercialization and diffusion of technologies. A New Categorization of the U.S. Economy: The Role of Supply Chain Industries in Innovation and Economic Performance By: Delgado, Mercedes,... View Details
Keywords: Dina Gerdeman
- December 2012 (Revised November 2014)
- Case
W.R. Grace & Co.: Dealing with Asbestos Torts
By: Stuart C. Gilson and Sarah L. Abbott
A manufacturer of building products and specialty chemicals, W. R. Grace & Co. filed for Chapter 11 bankruptcy in 2001 in response to a flood of lawsuits alleging that its products contained asbestos, and had caused hundreds of thousands of people to contract... View Details
Keywords: Bankruptcy Reorganization; Business Failures; Environmental Regulations; Class Action Lawsuits; Natural Environment; Valuation; Health Disorders; Capital Structure; Restructuring; Lawsuits and Litigation; Chemicals; Crisis Management; Insolvency and Bankruptcy; Legal Liability; Construction Industry; Construction Industry; United States
Gilson, Stuart C., and Sarah L. Abbott. "W.R. Grace & Co.: Dealing with Asbestos Torts." Harvard Business School Case 213-046, December 2012. (Revised November 2014.)
- 10 Mar 2021
- News
Chasing the Silver Tsunami
Thriving Online After three decades in service of people who are over the age of 50, Meredith Oppenheim is working to nudge the industry in a new direction—broadening the scope of its offerings to include meaningful online engagement. Her... View Details
- 31 Mar 2009
- First Look
First Look: March 31, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=809089 LeBron James Harvard Business School Case 509-050 In 2005, to the astonishment of many sports industry insiders, superstar basketball player LeBron James fired his... View Details
Keywords: Martha Lagace
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- 02 Jun 2021
- News
HBS Announces 2021-22 Blavatnik Fellows
provides mentorship during their entrepreneurial journey. To date, Blavatnik Fellows have created 26 companies in biomedical industries including devices, diagnostics, digital health, and therapeutics, and have collectively raised more... View Details
- 18 Feb 2015
- First Look
First Look: February 18
authors go beyond the common belief of retail as a monolithic industry and provide a framework that any brick-and-mortar retailer can use to respond to the eCommerce threat. Through six examples, this book demonstrates how this framework... View Details
Keywords: Sean Silverthorne
- Working Paper
Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Rising list prices are often used to illustrate the burden of prescription drug spending, but payers routinely negotiate rebates from manufacturers that generate differences between list and net prices. List prices are easily available and affect patient cost-sharing,... View Details
Keywords: Pharmaceuticals; Rebates; Health Care and Treatment; Markets; Price; Analysis; Pharmaceutical Industry
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S." NBER Working Paper Series, No. 26846, March 2020.
- November 1999
- Supplement
"ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995
Provides excerpts from an interview with Peter Staley of Act Up reflecting on the Wall Street protest against Burroughs Wellcome in the fall of 1989 and on the role and impact of AIDS advocacy and activism in general. View Details
Emmons, Willis M., III. "ACT UP": Peter Staley, An Interview with Professor Willis Emmons, November 17, 1995. Harvard Business School Video Supplement 700-501, November 1999.
- 09 Sep 2008
- First Look
First Look: September 9, 2008
Schoar, Jialan Wang Download the paper: http://www.hbs.edu/research/pdf/09-024.pdf The Contingent Nature of Public Policy and Growth Strategies in the Early Twentieth-Century U.S. Banking Industry Authors:Christopher Marquis, Zhi Huang... View Details
Keywords: Sean Silverthorne
- 01 Sep 2010
- News
Head Games
legislation intended to protect the health of minors? The Bulletin first looked at the business of sports in 1998 with a cover story titled “Running Up the Score.” That article featured Stephen A. Greyser, Richard P. Chapman Professor... View Details
- 01 Jun 2020
- News
Post-Office
call with his team. “I think the decision drove a tremendous amount of confidence,” he says. He saw many of his peers in the tech industry scrambling; Stack Overflow, in contrast, was inherently prepared for the transition. Lumry Family... View Details
- 10 Oct 2007
- First Look
First Look: First Look: October 10
spending associated with the redemption of such a coupon is focused on "marginal" grocery items, or grocery items that a customer does not typically buy. Download the paper: http://www.hbs.edu/research/pdf/08-024.pdf The Causes and Consequences of View Details
Keywords: Martha Lagace
- July 2020
- Technical Note
Digital Natives Growing Without a Sales Force
By: Das Narayandas, Michael Norris and Amram Migdal
This brief case describes the rise of so-called digital natives (also called born-in-digital) in the 2000s and 2010s that successfully grew without a sales force. The case highlights the emergence of business-to-business Internet and cloud-based companies and their... View Details
Keywords: Government Administration; Crisis Management; Health; Health Pandemics; Innovation and Invention; Innovation Leadership; Innovation Strategy; Technological Innovation; Social Issues; Information Technology; Mobile and Wireless Technology; Applications and Software; Technology Adoption; Information Technology Industry; Australia; North and Central America; United States; Illinois; Chicago; California; San Francisco
Narayandas, Das, Michael Norris, and Amram Migdal. "Digital Natives Growing Without a Sales Force." Harvard Business School Technical Note 521-019, July 2020.
- 16 Jan 2018
- News
Celebrating the Impact of Nonprofits
SPNM scholarship program a primary focus of its fundraising activities because the program’s impact in the region is so far-reaching. “Our members have been most motivated to give back to the community through SPNM,” says Panoff. “This is an old View Details
Keywords: Margie Kelley
- November 2008 (Revised July 2009)
- Background Note
A Managerial Perspective on Clinical Trials
By: Arthur A. Daemmrich
This note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Product Development; Safety; Biotechnology Industry; Biotechnology Industry
Daemmrich, Arthur A. "A Managerial Perspective on Clinical Trials." Harvard Business School Background Note 709-033, November 2008. (Revised July 2009.)